NCT07090629View on ClinicalTrials.gov

The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

May 6, 2024

Primary Completion Date

December 29, 2024

Study Completion Date

March 21, 2025

Conditions
High CholesterolLipodystrophy, Familial PartialDiabetes
Interventions
OTHER

Epicardial adipose tissue measurement on the available tododensitometry used for coronary calcium scoring

Epicardial adipose tissue measurement

Trial Locations (1)

Unknown

CHU de La Réunion, Saint-Pierre

All Listed Sponsors
collaborator

Aix Marseille Université

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

OTHER

lead

Centre Hospitalier Universitaire de la Réunion

OTHER

NCT07090629 - The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island. | Biotech Hunter | Biotech Hunter